[go: up one dir, main page]

MX2019002455A - Metodos para la identificacion de epitopes. - Google Patents

Metodos para la identificacion de epitopes.

Info

Publication number
MX2019002455A
MX2019002455A MX2019002455A MX2019002455A MX2019002455A MX 2019002455 A MX2019002455 A MX 2019002455A MX 2019002455 A MX2019002455 A MX 2019002455A MX 2019002455 A MX2019002455 A MX 2019002455A MX 2019002455 A MX2019002455 A MX 2019002455A
Authority
MX
Mexico
Prior art keywords
methods
protein
identifying epitopes
epitopes
identifying
Prior art date
Application number
MX2019002455A
Other languages
English (en)
Inventor
Trkulja Carolina
Orwar Owe
Davidson Max
Original Assignee
Oblique Therapeutics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oblique Therapeutics Ab filed Critical Oblique Therapeutics Ab
Publication of MX2019002455A publication Critical patent/MX2019002455A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medical Informatics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Library & Information Science (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)

Abstract

La presente invención se refiere a métodos para identificar un epítope en una proteína que se puede unir por un anticuerpo. Los métodos de la invención normalmente involucran una etapa de proteólisis limitada o restringida de una proteína y la identificación de sitios en la proteína que son escindidos por la proteasa o proteasas utilizadas. La invención también se refiere a anticuerpos que se unen a epítopes que han sido identificados mediante los métodos de la invención.
MX2019002455A 2016-09-01 2017-09-01 Metodos para la identificacion de epitopes. MX2019002455A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1614884.3A GB201614884D0 (en) 2016-09-01 2016-09-01 Method
PCT/EP2017/072001 WO2018042010A1 (en) 2016-09-01 2017-09-01 Methods of identifying epitopes

Publications (1)

Publication Number Publication Date
MX2019002455A true MX2019002455A (es) 2019-05-30

Family

ID=57140094

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019002455A MX2019002455A (es) 2016-09-01 2017-09-01 Metodos para la identificacion de epitopes.

Country Status (16)

Country Link
US (1) US20190194320A1 (es)
EP (1) EP3507604A1 (es)
JP (3) JP7032386B2 (es)
KR (1) KR102441148B1 (es)
CN (1) CN109791156B (es)
AU (1) AU2017321032B2 (es)
BR (1) BR112019004025A2 (es)
CA (1) CA3035318A1 (es)
GB (1) GB201614884D0 (es)
IL (1) IL265123B2 (es)
MA (1) MA46088A (es)
MX (1) MX2019002455A (es)
NZ (1) NZ752191A (es)
RU (1) RU2771584C2 (es)
SG (1) SG11201901603RA (es)
WO (1) WO2018042010A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4321870B1 (en) * 2018-03-13 2025-07-30 Amgen Inc. Methods for the preparation of trypsin-resistant polypeptides for mass spectrometric analysis
CN119252379B (zh) * 2024-09-23 2025-06-20 上海分子之心智能科技有限公司 一种预测抗原表位信息的方法、设备、介质及程序产品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2303264C2 (ru) * 2001-02-19 2007-07-20 Мерк Патент Гмбх Способ идентификации эпитопов т-клеток и его применение для получения молекул со сниженной иммуногенностью
TWI385180B (zh) * 2003-07-15 2013-02-11 安美基公司 作為選擇性神經生長因子（ｎｇｆ）通道抑制劑之人類抗-ｎｇｆ中和抗體
US10501531B2 (en) * 2013-03-13 2019-12-10 Prothena Biosciences Limited Tau immunotherapy
MA41842A (fr) * 2015-03-31 2018-02-06 Oblique Therapeutics Ab Nouveaux procédés de sélection d'épitope

Also Published As

Publication number Publication date
AU2017321032A1 (en) 2019-04-18
RU2019105088A (ru) 2020-10-01
US20190194320A1 (en) 2019-06-27
IL265123B1 (en) 2024-04-01
WO2018042010A1 (en) 2018-03-08
BR112019004025A2 (pt) 2019-08-20
JP2024037751A (ja) 2024-03-19
KR102441148B1 (ko) 2022-09-06
CA3035318A1 (en) 2018-03-08
KR20190045252A (ko) 2019-05-02
MA46088A (fr) 2019-07-10
RU2019105088A3 (es) 2020-12-21
JP2022033845A (ja) 2022-03-02
IL265123B2 (en) 2024-08-01
JP2019536427A (ja) 2019-12-19
EP3507604A1 (en) 2019-07-10
JP7032386B2 (ja) 2022-03-08
AU2017321032B2 (en) 2024-05-30
IL265123A (es) 2024-04-01
SG11201901603RA (en) 2019-03-28
RU2771584C2 (ru) 2022-05-06
GB201614884D0 (en) 2016-10-19
CN109791156A (zh) 2019-05-21
NZ752191A (en) 2023-03-31
CN109791156B (zh) 2022-11-22

Similar Documents

Publication Publication Date Title
PH12018502478A1 (en) Bispecific binding proteins binding an immunomodulatory protein and a tumor antigen
CR20170383A (es) Anticuerpos anti-cd3, anticuerpos anti-cd-123 y anticuerpos biespecíficos que se unen específicamente a cd3 y/o cd123
PH12019502087A1 (en) Anti-par2 antibodies and uses thereof
BR112018070948A2 (pt) anticorpos anti-psma e utilização dos mesmos
EP3954703A3 (en) Tri-specific binding molecules and methods of use thereof
CO2018005436A2 (es) Anticuerpos y fragmentos de anticuerpo para la conjugación sitio-específica
MX2017001597A (es) Anticuerpos anti-pd-l1.
CR20190227A (es) Proteínas de fusión heterodiméricas biespecíficas que contienen proteínas de fusión fc il-15/il-15ra y fragmentos de anticuerpo pd-1
WO2015184001A8 (en) Anti-tnf-alpha glycoantibodies and uses thereof
EA201891582A1 (ru) Иммуностимулирующие гуманизированные моноклональные антитела против интерлейкина-2 человека и их слитые белки
BR112018006251A2 (pt) anticorpos antagonistas que se ligam especificamente a cd40 humano e métodos de uso
BR112018012344A2 (pt) anticorpos que se ligam especificamente a hla-dr e seus usos
HK1249124A1 (zh) 用於表位选择的新方法
EA201990672A1 (ru) Антитела, специфически связывающиеся с pd-1, и их функциональные фрагменты
EA201990673A1 (ru) Антитела, специфически связывающиеся с il-17a, и их функциональные фрагменты
WO2015006337A3 (en) Compositions and methods for increasing protein half-life in a serum
MX2019003908A (es) Metodo por multiproteasa.
MX2018005831A (es) Gradientes de ph-sal opuestos para separaciones de proteina mejoradas.
WO2020127354A3 (en) Polypeptides
PH12016501579A1 (en) Novel anti-presepsin antibody
EA201892231A1 (ru) Способ очистки белка
SG11201810779PA (en) Method for screening antibody using patient-derived tumor spheroids
MX2019002455A (es) Metodos para la identificacion de epitopes.
MX2016011177A (es) Anticuerpos a la metaloproteinasa de matriz 9 y metodos de uso de los mismos.
WO2017209553A3 (ko) 환자 유래 세포를 이용한 항체 스크리닝 방법